Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Toll-like receptor (TLR) abnormalities, particularly increased TLR4, are implicated in depression.
• Previous research noted TLR expression differences in major depressive disorder (MDD) patients' peripheral blood mononuclear cells (PBMCs).
• While psychotherapy normalized TLR4, antidepressant effects on TLRs remained unclear.

Purpose of the Study:

• To investigate changes in Toll-like receptor (TLR) 1-9 expression in PBMCs of MDD patients.
• To assess the impact of antidepressant treatment on TLR expression levels.
• To explore the relationship between TLR expression and depression severity.

Main Methods:

• Examined TLR1-9 mRNA expression in PBMCs from 56 MDD patients using qRT-PCR.
• Assessed depression severity using the 17-item Hamilton Depression Rating Scale (HAMD-17).
• Measured TLR expression and HAMD-17 scores before and after 4 weeks of antidepressant treatment.

Main Results:

• Elevated TLR3, TLR4, TLR5, TLR7, TLR8, and TLR9 levels in MDD patients decreased significantly after 4 weeks of antidepressant treatment.
• Antidepressant treatment normalized TLR3, TLR5, TLR7, TLR8, and TLR9, while TLR1, TLR2, TLR4, and TLR6 decreased below normal levels.
• Lower baseline TLR3 expression predicted greater improvement in HAMD-17 scores, indicating its role in treatment response.

Conclusions:

• Antidepressant therapy demonstrates anti-inflammatory effects in MDD patients by modulating TLR expression.
• TLR profiles, particularly TLR3, may serve as predictors of antidepressant therapy response.
• Further research is warranted to elucidate the precise mechanisms of TLRs in depression and their therapeutic potential.